Stock Movers Oracle Drops, Lennar Falls, Medline Surges
Dec 17, 2025
Carmen Reineke, a Bloomberg News equities reporter, shares insights on market fluctuations and emerging trends. Oracle's shares drop 5.3% after Blue Owl Capital backs out of a major data center deal. Meanwhile, Lennar forecasts disappointing housing market figures, missing expectations in orders and margins. In a surprising twist, Medline's IPO pops 30%, raising $6.26 billion in a sluggish market. Carmen unpacks these developments and discusses their implications for investors and the broader market landscape.
AI Snips
Chapters
Transcript
Episode notes
Huge Debut For Medline IPO
- Medline's IPO drew strong demand, pricing at $29 and jumping to about $39 in debut trading.
- The $6.26 billion raise made it the biggest IPO of the year and signaled investor enthusiasm.
Oracle Loses Key Financing Partner
- Oracle shares fell after reports that Blue Owl Capital will not back a $10 billion data center deal.
- Oracle said negotiations remain on schedule but investor confidence weakened, driving the share drop.
AI Trade Pullback Hits NVIDIA Hard
- NVIDIA's share decline erased roughly $150 billion in market value amid broader AI-trade weakness.
- Reports of OpenAI discussing chip funding with Amazon added perceived competition to NVIDIA's dominance.